Cogent Biosciences, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 6
EBIT TTM (mln): -261
index 0 1 2 3 4 5 6 7 8 9
Rok finansowy 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 3 6 8 10 22 8 0 0 0 0
Przychód Δ r/r 0.0% 112.8% 31.5% 16.4% 131.1% -65.0% -100.0% 0.0% 0.0% 0.0%
Marża brutto 100.0% 100.0% 100.0% 100.0% 99.8% 99.7% -inf% -inf% -inf% 0.0%
EBIT (mln) -7 -19 -26 -36 -32 -82 -76 -148 -208 -276
EBIT Δ r/r 0.0% 189.3% 37.1% 37.7% -10.6% 155.5% -8.1% 95.7% 40.8% 32.6%
EBIT (%) -220.8% -300.1% -312.8% -369.9% -143.0% -1044.3% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 0 0 0 0 4 0 0
EBITDA (mln) -6 -18 -25 -35 -32 -90 -75 -148 -205 -276
EBITDA(%) -214.8% -287.0% -298.8% -356.3% -143.0% -1139.5% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 -0 -0 1 -2 -8 -0 -8 0 0
Zysk Netto (mln) -7 -18 -25 -35 -30 -66 -72 -133 -192 -256
Zysk netto Δ r/r 0.0% 174.9% 40.7% 35.5% -12.3% 119.5% 8.1% 84.7% 45.1% 33.0%
Zysk netto (%) -220.8% -285.2% -304.9% -354.8% -134.6% -844.3% 0.0% 0.0% 0.0% 0.0%
EPS -1.13 -3.1 -3.45 -5.55 -3.97 -6.0 -1.85 -2.26 -2.42 -3.49
EPS (rozwodnione) -0.89 -2.45 -3.45 -5.55 -3.97 -6.0 -1.85 -2.26 -2.42 -3.49
Ilośc akcji (mln) 6 6 7 6 8 11 39 59 80 73
Ważona ilośc akcji (mln) 7 7 7 6 8 11 39 59 80 73
Waluta USD USD USD USD USD USD USD USD USD USD